Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
2.270
-0.140 (-5.81%)
At close: Apr 19, 2024, 4:00 PM
2.420
+0.150 (6.61%)
After-hours: Apr 19, 2024, 7:44 PM EDT
Taysha Gene Therapies Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for TSHA stock have an average target of 6.88, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 203.08% from the current stock price of 2.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TSHA stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 3 | 3 | 4 |
| Hold | 4 | 4 | 4 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +208.37% | Apr 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +208.37% | Apr 18, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +208.37% | Apr 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $9 | Buy | Initiates | $9 | +296.48% | Apr 9, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +208.37% | Mar 21, 2024 |
Financial Forecast
Revenue This Year
8.67M
from 15.45M
Decreased by -43.89%
Revenue Next Year
6.43M
from 8.67M
Decreased by -25.88%
EPS This Year
-0.41
from -0.96
EPS Next Year
-0.49
from -0.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.0M | 15.8M | 3.2M | 53.2M | 158.8M |
| Avg | 8.7M | 6.4M | 1.5M | 25.4M | 80.8M |
| Low | n/a | n/a | n/a | n/a | 37.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 23.0% | 81.7% | -51.0% | 3,379.4% | 524.3% |
| Avg | -43.9% | -25.9% | -76.2% | 1,562.2% | 217.5% |
| Low | - | - | - | - | 48.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.32 | -0.37 | -0.49 | -0.26 | -0.43 |
| Avg | -0.41 | -0.49 | -0.59 | -0.47 | -0.53 |
| Low | -0.56 | -0.62 | -0.67 | -0.66 | -0.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.